Abstract  Radiotherapy (RT) and concomitant/adjuvant therapy with temozolomide (Temodar) is a ordinary communication program for children
and adults with glioma. Although temozolomide is mostly substantially tolerated with temporary myelosuppression as the direct dose-limiting
toxicity, permanent bone-marrow aplasia after communication with temozolomide has been reported. We inform the housing of an adolescent
enduring with a high-grade glioma who, after >2 years of event-free survival, underwent flourishing pearl goody transplantation
for communication of temozolomide-induced nonindulgent aplastic anaemia (SAA).

Content Type Journal ArticleCategory Case reportDOI 10.1007/s11060-008-9704-4Authors
E. Brannon Morris, St. Thaddaeus Children’s Research Hospital Department of Oncology 332 N. Lauderdale St., Mail Stop 735 metropolis TN 38105 USAKimberly Kasow, St. Thaddaeus Children’s Research Hospital Department of Oncology 332 N. Lauderdale St., Mail Stop 735 metropolis TN 38105 USAUlrike Reiss, St. Thaddaeus Children’s Research Hospital Department of Hematology 332 N. Lauderdale St., Mail Stop 735 metropolis TN 38105 USADavid Ellison, St. Thaddaeus Children’s Research Hospital Department of Pathology 332 N. Lauderdale St., Mail Stop 735 metropolis TN 38105 USAAlberto Broniscer, St. Thaddaeus Children’s Research Hospital Department of Oncology 332 N. Lauderdale St., Mail Stop 735 metropolis TN 38105 USA

Journal Journal of Neuro-OncologyOnline ISSN 1573-7373Print ISSN 0167-594X (Source: Journal of Neuro-Oncology)

Tags: ATM, Ellison, glioma, Hospital, Lim, Toxicity, transplantation